Literature DB >> 17332682

Are the endothelial mechanisms of ACE-Is already established?

Włodzimierz Buczko1, Karol Kramkowski, Andrzej Mogielnicki.   

Abstract

The endothelial mechanism of ACE-Is action is multifaceted. On the one hand, by inhibiting ACE, ACE-Is diminish Ang II synthesis, one of the best known active peptides. On the other hand, they modify synthesis and release of PGI(2) and NO via increasing production of other biologically important peptides like bradykinin, Ang-(1-7) or Ang-(1-9). Thus, ACE-Is play a crucial role in the function of endothelium and are effective and important tool for therapy of range of cardiovascular system disorders. Moreover, they are sensitive pharmacological instrument to elucidate and expand our knowledge about the role of RAS in human patophysiology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17332682

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  6 in total

Review 1.  Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril.

Authors:  Claudio Borghi; Arrigo F G Cicero
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

2.  Role of ACE I/D gene polymorphisms on the effect of ramipril in inflammatory response and myocardial injury in patients undergoing coronary artery bypass grafts.

Authors:  Meral Urhan Küçük; Nehir Sucu; Seyhan Şahan Firat; Barlas Naim Aytaçoğlu; Özden Vezir; Caner Bozali; Necmiye Canacankatan; Seval Kul; Bahar Tunçtan
Journal:  Eur J Clin Pharmacol       Date:  2014-09-27       Impact factor: 2.953

3.  Development of a novel nanoflow liquid chromatography-parallel reaction monitoring mass spectrometry-based method for quantification of angiotensin peptides in HUVEC cultures.

Authors:  Chuan He; Simiao Hu; Wanxing Zhou
Journal:  PeerJ       Date:  2020-09-15       Impact factor: 2.984

4.  Cardiovascular changes in spontaneously hypertensive rats are improved by chronic treatment with zofenopril.

Authors:  M Gómez-Roso; M J Montero; R Carrón; M A Sevilla
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

5.  Quinapril decreases antifibrinolytic and prooxidative potential of propofol in arterial thrombosis in hypertensive rats.

Authors:  Marzena Wojewodzka-Zelezniakowicz; Wioleta Kisiel; Karol Kramkowski; Anna Gromotowicz-Poplawska; Agnieszka Zakrzeska; Adrian Stankiewicz; Patrycjusz Kolodziejczyk; Janusz Szemraj; Jerzy Robert Ladny; Ewa Chabielska
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-05-11       Impact factor: 1.636

6.  Early Treatment With Zofenopril and Ramipril in Combination With Acetyl Salicylic Acid in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results of a 5-Year Follow-up of Patients of the SMILE-4 Study.

Authors:  Claudio Borghi; Stefano Omboni; Salvatore Novo; Dragos Vinereanu; Giuseppe Ambrosio; Ettore Ambrosioni
Journal:  J Cardiovasc Pharmacol       Date:  2017-05       Impact factor: 3.105

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.